Literature DB >> 19859710

[Predictive EGFR gene analyses in cytology].

L Bubendorf1, S Savic.   

Abstract

EGFR mutations and EGFR gene copy number are considered as predictive markers for response to EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC).NSCLC are often diagnosed by cytology alone. The isolation or selection of a pure tumour cell population is critical for mutation analysis by PCR and sequencing in order to avoid an admixture of tumour DNA with normal DNA of adjacent benign cells. The collection of tumour cells is easily possible by laser microdissection (LMD).EGFR FISH analysis on cytological specimens with a high proportion of benign respiratory cells should be performed after automated relocation of carcinoma cells. The only hitherto established EGFR-FISH criteria were developed using histological specimens and cannot be applied to cytological specimens as such. The cell nuclei in cytological specimens are intact, while they are often truncated in histological specimens. Therefore, when applying the Colorado criteria, the rate of FISH positive results is higher in cytological than in histological specimens and in fact represents false positive results in cytology.Cytological specimens are equally well suited for EGFR gene analyses and FISH analysis as histological specimens. At present, the value of EGFR-FISH analysis is limited by the lack of validated criteria for FISH positivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19859710     DOI: 10.1007/s00292-009-1191-7

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  9 in total

Review 1.  Update on epidermal growth factor receptor mutations in non-small cell lung cancer.

Authors:  Gregory J Riely; Katerina A Politi; Vincent A Miller; William Pao
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

2.  Assessment of mean EGFR gene copy number is a highly reproducible method for evaluating FISH in histological and cytological cancer specimens.

Authors:  Inti Zlobec; Ines Raineri; Sandra Schneider; René Schoenegg; Bruno Grilli; Michelle Herzog; Spasenija Savic; Lukas Bubendorf
Journal:  Lung Cancer       Date:  2009-07-18       Impact factor: 5.705

Review 3.  Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer.

Authors:  Lecia V Sequist; Daphne W Bell; Thomas J Lynch; Daniel A Haber
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

4.  Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.

Authors:  Federico Cappuzzo; Fred R Hirsch; Elisa Rossi; Stefania Bartolini; Giovanni L Ceresoli; Lynne Bemis; Jerry Haney; Samir Witta; Kathleen Danenberg; Irene Domenichini; Vienna Ludovini; Elisabetta Magrini; Vanesa Gregorc; Claudio Doglioni; Angelo Sidoni; Maurizio Tonato; Wilbur A Franklin; Lucio Crino; Paul A Bunn; Marileila Varella-Garcia
Journal:  J Natl Cancer Inst       Date:  2005-05-04       Impact factor: 13.506

Review 5.  Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

Authors:  David A Eberhard; Giuseppe Giaccone; Bruce E Johnson
Journal:  J Clin Oncol       Date:  2008-02-20       Impact factor: 44.544

6.  [EGFR mutation analysis in non-small-cell lung cancer : Experience from routine diagnostics].

Authors:  C Tapia; S Savic; M Bihl; A Rufle; I Zlobec; L Terracciano; L Bubendorf
Journal:  Pathologe       Date:  2009-09       Impact factor: 1.011

Review 7.  Impact of EGFR mutation analysis in non-small cell lung cancer.

Authors:  Hiromasa Yamamoto; Shinichi Toyooka; Tetsuya Mitsudomi
Journal:  Lung Cancer       Date:  2008-08-29       Impact factor: 5.705

8.  MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Authors:  Jeffrey A Engelman; Kreshnik Zejnullahu; Tetsuya Mitsudomi; Youngchul Song; Courtney Hyland; Joon Oh Park; Neal Lindeman; Christopher-Michael Gale; Xiaojun Zhao; James Christensen; Takayuki Kosaka; Alison J Holmes; Andrew M Rogers; Federico Cappuzzo; Tony Mok; Charles Lee; Bruce E Johnson; Lewis C Cantley; Pasi A Jänne
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

9.  Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers.

Authors:  S Savic; C Tapia; B Grilli; A Rufle; M P Bihl; A de Vito Barascud; M Herzog; L Terracciano; F Baty; L Bubendorf
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

  9 in total
  2 in total

Review 1.  [Non-small cell lung cancer. Subtyping and predictive molecular marker investigations in cytology].

Authors:  S Savic; M P Bihl; L Bubendorf
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

Review 2.  [Resistance to medicinal tumor therapy. Current status].

Authors:  H Lage; U Kellner
Journal:  Pathologe       Date:  2013-09       Impact factor: 1.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.